Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iressa in chemo- and hormone-resistant breast cancer
NCT00428896Phase 2Completed
- Sponsor
- University Hospital of Crete
- Start
- Apr 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in breast cancer, sponsored by University Hospital of Crete. Started Apr 2005; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00428896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00428896.